Jay R. Luly Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 5 months, 3 weeks ago
Jay R. Luly has an estimated net worth of at least $10.5 million*, as of Nov. 20, 2024. They own 864,654 shares of ENTA stock. They have sold 74,800 shares of ENTA stock since 2021, for an estimated $2.9 million.
Jay R. Luly $ENTA SEC Form 4 Insider Trading
Jay R. Luly has filed a total of 10 insider trades in $ENTA since 2021. Their most recent trade was a purchase of 45,000 shares, made on Feb 12, 2025. Their largest trade was a purchase of 45,000 shares, made on Feb 12, 2025. We estimate that they now own 864,654 shares of $ENTA, worth an estimated $7.6 million.
Insider Trading at $ENTA
There have been a total of 58 insider trades reported at $ENTA since 2021, with 45,000 shares purchased and 340,575 shares sold. The most active insider traders in $ENTA stock have been Nathalie Adda, Jay R. Luly, and Paul J Mellett. The most recent trade was a purchase of 45,000 shares reported by Jay R. Luly (President and CEO), made on Feb 12, 2025.
History of Insider Stock Trades by Jay R. Luly
Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
---|---|---|---|---|
![]() |
Purchase | 45,000 | Feb 12, 2025 | Feb. 12, 2025, 9:09 p.m. |
![]() |
Sale | 5,142 | Dec 06, 2024 | Dec. 10, 2024, 5:55 p.m. |
![]() |
Sale | 7,230 | Dec 05, 2023 | Dec. 6, 2023, 9:17 p.m. |
![]() |
Sale | 10,697 | Mar 13, 2023 | March 14, 2023, 6:26 p.m. |
![]() |
Sale | 15,649 | Mar 13, 2023 | March 14, 2023, 6:26 p.m. |
![]() |
Sale | 1,566 | Mar 13, 2023 | March 14, 2023, 6:26 p.m. |
![]() |
Sale | 7,800 | Dec 16, 2022 | Dec. 16, 2022, 10:44 p.m. |
![]() |
Sale | 8,597 | Dec 16, 2022 | Dec. 16, 2022, 10:44 p.m. |
![]() |
Sale | 13,603 | Dec 16, 2022 | Dec. 16, 2022, 10:44 p.m. |
![]() |
Sale | 4,516 | Sep 15, 2021 | Sept. 16, 2021, 8 p.m. |
$ENTA Executives and Stock Owners with Insider Trades
-
Nathalie Adda, Sr. VP & Chief Medical Officer
-
Jay R. Luly, President and CEO
-
Paul J Mellett, Treasurer and CFO
-
Scott T. Rottinghaus, Chief Medical Officer
-
Tara Lynn Kieffer, Chief Product Strategy Officer
-
Yat Sun Or, Sr. VP & CSO
-
Brendan Luu, Chief Business Officer
-
Brendan Luu, Sr. VP, Business Dev.
-
Nathaniel S. Gardiner, Sr. VP & General Counsel
-
Paul J Mellett, Chief Fin. & Admin Officer
-
Paul J Mellett, Sr. VP, Finance & Admin. & CFO
-
Scott T. Rottinghaus, Sr. VP & CMO
-
Tara Lynn Kieffer, Sr. VP, New Prod. Strat. & Dev
-
Yat Sun Or, Chief Scientific Officer
-
Yat Sun Or, Sr. VP, R&D & CSO
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.